Clotrimazole (CAS 23593-75-1) is a broad-spectrum imidazole antifungal agent, widely used in clinical and daily care for preventing and treating fungal infections caused by various pathogenic fungi. Its main applications are categorized as follows:
Clotrimazole exerts its antifungal effect by inhibiting the synthesis of ergosterol, a key component of the fungal cell membrane, thereby disrupting membrane integrity and killing or inhibiting fungal growth. It is formulated into various topical preparations for different parts of the body:
Systemic formulations of clotrimazole (e.g., oral tablets) are rarely used clinically, because of their relatively low efficacy and potential side effects (e.g., gastrointestinal discomfort, liver function damage). Systemic antifungal drugs such as fluconazole or itraconazole are preferred for severe systemic fungal infections. However, in some cases, it may be used as an alternative for patients who are intolerant to other drugs.
Clotrimazole is also used in veterinary medicine to treat fungal infections in pets (e.g., cats, dogs), such as skin ringworm caused by Microsporum or Trichophyton species, with dosage forms including topical ointments or sprays.
Combined with other drugs: Mixed with corticosteroids (e.g., betamethasone) to prepare compound preparations, which can simultaneously treat fungal infections and relieve inflammatory reactions such as redness and swelling.
Preventive use: In high-risk groups (e.g., people who often wear closed shoes, patients with diabetes), topical clotrimazole can be used to prevent the occurrence of fungal infections.
China
